Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-11-015253

Options or other derivatives

  • Director acquired 87,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FORBES CHRISTOPHER · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2011-11-16 Grant or award : show line 1 in the form Common Stock Option +87,500 $0.22 2016-11-16 87,500 1,018,739 D
Loading xslF345X03/edgar.xml…